Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Takeda Pharmaceutical Co ADR (NYSE: TAK) closed the day trading at $13.44 down -0.37% from the previous closing price of $13.49. In other words, the price has decreased by -$0.37 from its previous closing price. On the day, 0.96 million shares were traded. TAK stock price reached its highest trading level at $13.47 during the session, while it also had its lowest trading level at $13.38.
Ratios:
For a better understanding of TAK, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.10 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.48. For the most recent quarter (mrq), Quick Ratio is recorded 0.77 and its Current Ratio is at 1.28. In the meantime, Its Debt-to-Equity ratio is 0.73 whereas as Long-Term Debt/Eq ratio is at 0.64.
On July 19, 2022, Cowen Upgraded its rating to Outperform which previously was Market Perform and also upped its target price recommendation from $21 to $24.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 23 ’24 when Giles Richard Platford bought 19,073 shares for $14.94 per share.
TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares of TAK for $29,999,994 on Jan 24 ’24. The 10% Owner now owns 3,755,583 shares after completing the transaction at $8.10 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TAK now has a Market Capitalization of 42609639424 and an Enterprise Value of 4772527079424. As of this moment, Takeda’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.29, and their Forward P/E ratio for the next fiscal year is 28.89. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.67. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.41 while its Price-to-Book (P/B) ratio in mrq is 0.88. Its current Enterprise Value per Revenue stands at 1.05 whereas that against EBITDA is 3.592.
Stock Price History:
Over the past 52 weeks, TAK has reached a high of $15.08, while it has fallen to a 52-week low of $12.57. The 50-Day Moving Average of the stock is -4.35%, while the 200-Day Moving Average is calculated to be -3.19%.
Shares Statistics:
Over the past 3-months, TAK traded about 1.73M shares per day on average, while over the past 10 days, TAK traded about 2367690 shares per day. A total of 3.17B shares are outstanding, with a floating share count of 3.17B. Insiders hold about 0.02% of the company’s shares, while institutions hold 5.17% stake in the company. Shares short for TAK as of 1731628800 were 5661796 with a Short Ratio of 3.49, compared to 1728950400 on 7299215. Therefore, it implies a Short% of Shares Outstanding of 5661796 and a Short% of Float of 0.18000001.
Dividends & Splits
TAK’s forward annual dividend rate is 0.29, up from 192.0 a year ago. Against a Trailing Annual Dividend Yield of 14.232765The stock’s 5-year Average Dividend Yield is 4.7.
